Aligos Therapeutics Inc. (ALGS) Presents Positive Clinical Data from ALG-055009 and ALG-000184 Phase 1 Studies streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Aligos Therapeutics, Inc. (NASDAQ:ALGS – Get Free Report) was the target of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 894,500 shares, a growth of 6.4% from the January 15th total of 840,400 shares. Based on an average daily volume of 294,500 shares, […]
Aligos Therapeutics (NASDAQ:ALGS – Get Free Report) and INmune Bio (NASDAQ:INMB – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings. Risk and Volatility Aligos Therapeutics has a […]